<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01405898</url>
  </required_header>
  <id_info>
    <org_study_id>08/H0703/91 Chronic</org_study_id>
    <nct_id>NCT01405898</nct_id>
  </id_info>
  <brief_title>The Chronic Effects of Beetroot Juice in Hypertensive Subjects</brief_title>
  <official_title>The Chronic Effects of Beetroot Juice on Circulating Plasma Nitrate and Nitrite Levels and Blood Pressure in Hypertensive Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Queen Mary University of London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Queen Mary University of London</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We are interested in the effect of diet on blood pressure. Our previous research has shown
      that beetroot juice lowers blood pressure in healthy people. We now want to see if beetroot
      juice has this effect in people with high blood pressure. Beetroot juice is naturally rich in
      nitrate (also found in most other vegetables but particularly in green leafy vegetables). We
      think that it is the nitrate that lowers the blood pressure.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">May 2014</completion_date>
  <primary_completion_date type="Actual">April 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Difference in Change in Clinic Systolic Blood Pressure From Baseline</measure>
    <time_frame>4 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Difference in Change in Clinic Diastolic Blood Pressure From Baseline</measure>
    <time_frame>4 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Difference in Change in Ambulatory Systolic Blood Pressure From Baseline</measure>
    <time_frame>4 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Difference in Change in Ambulatory Diastolic Blood Pressure From Baseline</measure>
    <time_frame>4 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Difference in Change in Plasma Nitrite Concentration From Baseline</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in Change in Endothelial Function From Baseline</measure>
    <time_frame>4 weeks</time_frame>
    <description>as measured by flow-mediated dilatation [%change in diameter of vessel] - an increase in diameter demonstrates an improvement in endothelial function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in Change in Arterial Stiffness From Baseline</measure>
    <time_frame>4 weeks</time_frame>
    <description>carotid-femoral pulse wave velocity [m/s] measured by Vicorder</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">68</enrollment>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>Beetroot Juice</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Nitrate-free beetroot juice</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>beetroot juice</intervention_name>
    <description>Beetroot juice 4 weeks 250ml daily</description>
    <arm_group_label>Beetroot Juice</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Nitrate-free beetroot juice</intervention_name>
    <description>Nitrate-free beetroot juice 4 weeks 250ml daily</description>
    <arm_group_label>Nitrate-free beetroot juice</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        A subject will be eligible for inclusion in this study only if all of the following
        criteria apply:

          1. Healthy adult male and females between 18 and 85 years of age, inclusive.

          2. To be eligible, female subjects will be required to state that they are not pregnant,
             and will not become pregnant during the course of the study.

          3. Body mass index (BMI) between 18 and 40 kg/m2

          4. A signed and dated written informed consent prior to admission to the study

          5. The subject is able to understand and comply with protocol requirements, instructions
             and protocol--‐stated restrictions.

        and either of the following categories of blood pressure

        Category 1--‐Pre--‐hypertensive SBP 130--‐139 or DBP 85--‐89 on no antihypertensives and
        will not commence antihypertensives during the course of the study.

        Category 2--‐Grade 1 hypertensive SBP 140--‐159 or DBP 90--‐99 on no anti--‐hypertensives,
        no target organ damage (TOD), low cardiovascular disease (CVD) risk Category
        3--‐Uncontrolled severe resistant (Grade 3) hypertensive with evidence of difficulty
        treating to target BP (140/85 or 130/80), with satisfactory adherence to at least one
        antihypertensive, but insufficient efficacy or intolerance of medications. (Category 3
        patients may also be on aspirin and/or a stable dose of cholesterol--‐lowering medications
        e.g statins).

        Exclusion Criteria:

        A subject will not be eligible for inclusion in this study if any of the following criteria
        apply:

          1. History of symptomatic coronary artery disease, stroke, or other known atherosclerotic
             disease.

          2. History of chronic viral hepatitis (including presence of hepatitis B surface antigen
             or hepatitis C antibody), or other chronic hepatic disorders.

          3. History of increased liver function tests (ALT, AST) due to acute or chronic liver
             conditions, 3x above the upper limit of normal or bilirubin 1.5x above the upper limit
             of normal at screening.

          4. Renal impairment with creatinine clearance (eGFR) of &lt;50 ml/min at screening.

          5. Current poorly controlled diabetes mellitus, defined as HbA1c &gt;10% at Screen.

          6. Subjects with LDLc, &gt;7.5 mmol/l. Fasting TG level &gt;6mmol/l.

          7. History of heart failure defined as NYHA class II --‐ IV or those with known severe LV
             dysfunction (EF&lt;30%) regardless of symptomatic status

          8. History of malignancy within the past 5 years, other than non--‐melanoma skin cancer.

          9. Current life--‐threatening condition other than vascular disease (e.g., very severe
             chronic airways disease, HIV positive, life--‐threatening arrhythmias) that may
             prevent a subject from completing the study.

         10. Alcohol or drug abuse within the past 6 months.

         11. Use of an investigational device or investigational drug within 30 days or 5
             half--‐lives (whichever is the longer) preceding the first dose of study medication.

         12. Subjects who will commence or who are likely to commence treatment with
             non--‐steroidal anti--‐ inflammatory drugs (NSAIDs) (other than aspirin), from
             screening until study completion.

         13. Any non--‐stable dosing of ongoing medication regimens throughout the study trial.

         14. The subject has a three--‐month prior history of regular alcohol consumption exceeding
             an average weekly intake of &gt; 28 units (or an average daily intake of greater than 3
             units) for males, or an average weekly intake of &gt; 21 units (or an average daily
             intake of greater than 2 units) for females. 1 unit is equivalent to a half--‐pint
             (284mL) of beer/lager; 25mL measure of spirits or 125mL of wine; or a positive alcohol
             breath test at the screening visit

         15. A positive urine test for drugs of abuse (not related to known medications the subject
             is taking, i.e., codeine for pain management) or alcohol at screening or prior to
             study medication administration.

         16. Any other subject whom the Investigator deems unsuitable for the study (e.g., due to
             either medical reasons, laboratory abnormalities, expected study medication
             noncompliance, or subject's unwillingness to comply with all study--‐related study
             procedures).

         17. Subjects with rheumatoid arthritis, connective tissue disorders and other conditions
             known to be associated with chronic inflammation (e.g. Inflammatory Bowel Disease).

         18. Subjects with any acute infection, or significant trauma (burns, fractures).

         19. Subjects who have donated more than 500 mL of blood within 56 days prior to the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Amrita Ahluwalia</last_name>
    <role>Principal Investigator</role>
    <affiliation>Queen Mary University London</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Queen Mary University London</name>
      <address>
        <city>London</city>
        <zip>EC1M 6BQ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 28, 2011</study_first_submitted>
  <study_first_submitted_qc>July 28, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 29, 2011</study_first_posted>
  <results_first_submitted>November 3, 2015</results_first_submitted>
  <results_first_submitted_qc>November 3, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">December 9, 2015</results_first_posted>
  <last_update_submitted>December 8, 2015</last_update_submitted>
  <last_update_submitted_qc>December 8, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 8, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Queen Mary University of London</investigator_affiliation>
    <investigator_full_name>Amrita Ahluwalia</investigator_full_name>
    <investigator_title>Professor of Vascular Pharmacology</investigator_title>
  </responsible_party>
  <keyword>hypertension</keyword>
  <keyword>nitrite</keyword>
  <keyword>blood pressure</keyword>
  <keyword>endothelial function</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Beetroot Juice</title>
          <description>Beetroot juice, 4 weeks 250ml daily</description>
        </group>
        <group group_id="P2">
          <title>Nitrate-free Beetroot Juice</title>
          <description>Nitrate-free beetroot juice, 4 weeks 250ml daily</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="34"/>
                <participants group_id="P2" count="34"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="32"/>
                <participants group_id="P2" count="32"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Beetroot Juice</title>
          <description>Beetroot juice 4 weeks 250ml daily</description>
        </group>
        <group group_id="B2">
          <title>Nitrate-free Beetroot Juice</title>
          <description>Nitrate-free beetroot juice, 4 weeks 250ml daily</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="32"/>
            <count group_id="B2" value="32"/>
            <count group_id="B3" value="64"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="57.6" spread="13.9"/>
                    <measurement group_id="B2" value="56.3" spread="16.4"/>
                    <measurement group_id="B3" value="56.9" spread="15.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Difference in Change in Clinic Systolic Blood Pressure From Baseline</title>
        <time_frame>4 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Beetroot Juice</title>
            <description>Beetroot juice, 4 weeks 250ml daily</description>
          </group>
          <group group_id="O2">
            <title>Nitrate-free Beetroot Juice</title>
            <description>Nitrate-free beetroot juice, 4 weeks 250ml daily</description>
          </group>
        </group_list>
        <measure>
          <title>Difference in Change in Clinic Systolic Blood Pressure From Baseline</title>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="32"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-8.7" spread="8.2"/>
                    <measurement group_id="O2" value="-1.0" spread="8.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Difference in Change in Plasma Nitrite Concentration From Baseline</title>
        <time_frame>4 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Beetroot Juice</title>
            <description>Beetroot juice, 4 weeks 250ml daily</description>
          </group>
          <group group_id="O2">
            <title>Nitrate-free Beetroot Juice</title>
            <description>Nitrate-free beetroot juice, 4 weeks 250ml daily</description>
          </group>
        </group_list>
        <measure>
          <title>Difference in Change in Plasma Nitrite Concentration From Baseline</title>
          <units>umol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="32"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.53" spread="0.37"/>
                    <measurement group_id="O2" value="0.01" spread="0.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Difference in Change in Endothelial Function From Baseline</title>
        <description>as measured by flow-mediated dilatation [%change in diameter of vessel] - an increase in diameter demonstrates an improvement in endothelial function</description>
        <time_frame>4 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Beetroot Juice</title>
            <description>Beetroot juice, 4 weeks 250ml daily</description>
          </group>
          <group group_id="O2">
            <title>Nitrate-free Beetroot Juice</title>
            <description>Nitrate-free beetroot juice, 4 weeks 250ml daily</description>
          </group>
        </group_list>
        <measure>
          <title>Difference in Change in Endothelial Function From Baseline</title>
          <description>as measured by flow-mediated dilatation [%change in diameter of vessel] - an increase in diameter demonstrates an improvement in endothelial function</description>
          <units>% dilatation</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="32"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.9" spread="1.3"/>
                    <measurement group_id="O2" value="0.1" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Difference in Change in Clinic Diastolic Blood Pressure From Baseline</title>
        <time_frame>4 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Beetroot Juice</title>
            <description>Beetroot juice, 4 weeks 250ml daily</description>
          </group>
          <group group_id="O2">
            <title>Nitrate-free Beetroot Juice</title>
            <description>Nitrate-free beetroot juice, 4 weeks 250ml daily</description>
          </group>
        </group_list>
        <measure>
          <title>Difference in Change in Clinic Diastolic Blood Pressure From Baseline</title>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="32"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.2" spread="5.4"/>
                    <measurement group_id="O2" value="-0.7" spread="4.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Difference in Change in Ambulatory Systolic Blood Pressure From Baseline</title>
        <time_frame>4 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Beetroot Juice</title>
            <description>Beetroot juice, 4 weeks 250ml daily</description>
          </group>
          <group group_id="O2">
            <title>Nitrate-free Beetroot Juice</title>
            <description>Nitrate-free beetroot juice, 4 weeks 250ml daily</description>
          </group>
        </group_list>
        <measure>
          <title>Difference in Change in Ambulatory Systolic Blood Pressure From Baseline</title>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="32"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-6.6" spread="6.5"/>
                    <measurement group_id="O2" value="0.8" spread="4.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Difference in Change in Ambulatory Diastolic Blood Pressure From Baseline</title>
        <time_frame>4 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Beetroot Juice</title>
            <description>Beetroot juice, 4 weeks 250ml daily</description>
          </group>
          <group group_id="O2">
            <title>Nitrate-free Beetroot Juice</title>
            <description>Nitrate-free beetroot juice, 4 weeks 250ml daily</description>
          </group>
        </group_list>
        <measure>
          <title>Difference in Change in Ambulatory Diastolic Blood Pressure From Baseline</title>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="32"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.3" spread="6.0"/>
                    <measurement group_id="O2" value="0.9" spread="3.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Difference in Change in Arterial Stiffness From Baseline</title>
        <description>carotid-femoral pulse wave velocity [m/s] measured by Vicorder</description>
        <time_frame>4 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Beetroot Juice</title>
            <description>Beetroot juice, 4 weeks 250ml daily</description>
          </group>
          <group group_id="O2">
            <title>Nitrate-free Beetroot Juice</title>
            <description>Nitrate-free beetroot juice, 4 weeks 250ml daily</description>
          </group>
        </group_list>
        <measure>
          <title>Difference in Change in Arterial Stiffness From Baseline</title>
          <description>carotid-femoral pulse wave velocity [m/s] measured by Vicorder</description>
          <units>m/s</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="32"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.59" spread="0.93"/>
                    <measurement group_id="O2" value="0.01" spread="1.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>8 weeks</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Beetroot Juice</title>
          <description>Beetroot juice, 4 weeks 250ml daily</description>
        </group>
        <group group_id="E2">
          <title>Nitrate-free Beetroot Juice</title>
          <description>Nitrate-free beetroot juice, 4 weeks 250ml daily</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Professor Amrita Ahluwalia</name_or_title>
      <organization>Queen Mary University London</organization>
      <phone>02078825720</phone>
      <email>a.ahluwalia@qmul.ac.uk</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

